How Beliefs in Biological Differences Can Undergird Racial and Policy Attitudes
By Carson Byrd,
USAPP
| 08. 24. 2015
Untitled Document
It has been 15 years since then President Bill Clinton and leading scientists of the Human Genome Project made their highly-acclaimed proclamations that race at the genetic level does not exist. At the time this supported the long-held narrative of scholars that the once prominent beliefs in biological determinism (race as a genetic reality) and racial essentialism (human behavior is anchored in group-based biological differences) had been all but completely laid to rest in the archives of history, particularly after the fall of the Nazi regime and the end of the Holocaust after World War II. However, these beliefs in race and genetics may be making a comeback as genetic and genomic research gains in popularity and media visibility. As sociologist Lawrence Bobo and colleagues recently note in their analysis of survey data, there is a recent uptick the last decade in the belief that there are innate (i.e., biological or genetic) racial differences that drive racial inequality.
Many social scientists argue that since the peak of the Civil Rights Movement in the 1960s whites in the U.S...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...